Search Results for
July 26, 2022
Activists to Biden: Share Walter Reed Army Vaccine With the World
If the Walter Reed vaccine proves effective against Covid-19 and its variants in further tests, it will be a vaccine wholly created by a public institution through use of public funds. Every aspect of the vaccine production process should be widely and freely shared to ensure globally distributed manufacturing. Widespread, equitable availability of effective vaccines at truly affordable prices would go a long way in achieving your stated goal of vaccinating the world.
July 26, 2022
Advocates to President Biden: Don’t Give Away New Publicly-Owned Coronavirus Vaccine Technology to Corporations
In advance of the White House Summit on the Future of COVID-19 Vaccines today, 29 groups including Public Citizen, Demand Progress and Revolving Door Project, a project of the Center for Economic and Policy Research, sent a letter to President Joe Biden urging him to ensure that pan coronavirus vaccine technology currently under development by the U.S. military remain public, and shared with the world.
April 04, 2022 | The American Prospect
The Corporate Past Of Jeffrey Zients
Over the span of two decades, the health care companies that Zients controlled, invested in, and helped oversee were forced to pay tens of millions of dollars to settle allegations of Medicare and Medicaid fraud. They have also been accused of surprise-billing practices and even medical malpractice.
December 22, 2021 | Common Dreams
Free At-Home Tests Are a Start, But Biden Must Move Faster and Go Bigger to End Pandemic
The Covid-19 threat will not simply go away—especially when addressed with half measures. The administration must use its authority under the Defense Production Act much more wisely and aggressively.
September 29, 2021 | The American Prospect
How to Vaccinate the World
When United States Trade Representative Katherine Tai announced this past May that the U.S. would support the TRIPS waiver on COVID-19 vaccines at the World Trade Organization (WTO), we at the Revolving Door Project celebrated the administration’s decision as “a transformative, hopeful event.” The waiver proposal calls on the WTO’s Trade-Related Aspects of Intellectual Property Rights (TRIPS) Council to suspend intellectual-property protections on COVID-19 therapeutics, diagnostics, and vaccines to ensure materials necessary for combating the pandemic are “available promptly, in sufficient quantities and at affordable price to meet global demand.”
September 24, 2021
Biden Administration’s Inaction on Vaccine Equity is Cowardly and Shameful
“Over four months after announcing its support for the COVID-19 TRIPS Waiver, the Biden administration’s once promising step towards achieving vaccine equity is proving to be little more than an empty promise. Officials across the administration are cowering in the face of Big Pharma’s insatiable appetite for profit rather than pursuing one of many paths to rapidly ensure equitable access to vaccines worldwide.”
September 15, 2021
Do Not Give Gina Raimondo A Promotion
The Commerce Secretary is a dedicated corporate crony. Making her Treasury Secretary would be a catastrophic mistake.
August 19, 2021
The Fed's Municipal Lending Failed Black Public-Sector Workers
Disproportionately Black cities were the ones most in need of a non-profit-seeking investment alternative during the COVID-19 crisis. The Fed’s program to fill that need failed to deliver.
July 28, 2021
Revolver Spotlight: Elizabeth Fowler
Fowler, a former Johnson & Johnson executive, is the latest Biden hire to spin through Pharma’s revolving door.
May 05, 2021
Biden's TRIPS Waiver Decision Is A Transformative, Hopeful Event
The Revolving Door Project praises and congratulates the Biden administration for this excellent decision. This one choice may save millions of lives.
April 23, 2021 | The American Prospect
Place Human Lives Over Pharma’s Property Rights
The Biden administration is divided over whether to waive trade protections for Big Pharma—with Commerce Secretary Gina Raimondo as a key industry ally.
April 16, 2021
The Brother Of A Pharma Lobbyist Advises Biden As He Weighs Vaccine IP Waiver
Despite pushback from progressives, Ricchetti has continued to hold a powerful advisory position in the Biden White House. His background in corporate lobbying and strong ties to the pharmaceutical industry are deeply troubling signs as the Biden Administration faces enormously consequential decisions about how to end the COVID-19 pandemic.
April 16, 2021
Break Big Pharma's Stranglehold On COVID-19 Vaccines With Existing Powers, 16 Groups Tell Biden Admin
A coalition of 16 organizations called on Secretary of Commerce Gina Raimondo and COVID-19 Response Coordinator Jeffrey Zients to maximally use the executive branch’s existing powers to end the pharmaceutical industry’s stranglehold on supply on COVID-19 vaccines in an open letter today.
April 14, 2021
Big Pharma's Coils Around COVID-19 Vaccines Likely Protected By Raimondo, Zients, Ricchetti
The world deserves to know exactly who is responsible for the United States not yet supporting a waiver for intellectual property rights on COVID-19 vaccine production.